Total Payments
$2,647
2021 Payments
$19.03
Companies
11
Transactions
27
Payment Breakdown by Category
Travel$1,767 (66.7%)
Food & Beverage$585.66 (22.1%)
Research$295.00 (11.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,767 | 3 | 66.7% |
| Food and Beverage | $585.66 | 23 | 22.1% |
| Unspecified | $295.00 | 1 | 11.1% |
Payments by Type
General
$2,352
26 transactions
Research
$295.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals, Ltd | $1,887 | 7 | $0 (2018) |
| Actelion Clinical Research, Inc. | $295.00 | 1 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $145.87 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $88.56 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $69.47 | 4 | $0 (2020) |
| Genentech USA, Inc. | $65.68 | 4 | $0 (2019) |
| Allergan Inc. | $26.82 | 2 | $0 (2019) |
| VERTEX PHARMACEUTICALS INCORPORATED | $22.04 | 1 | $0 (2020) |
| AbbVie Inc. | $19.03 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $16.65 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $19.03 | 1 | AbbVie Inc. ($19.03) |
| 2020 | $117.77 | 5 | GlaxoSmithKline, LLC. ($59.30) |
| 2019 | $139.69 | 9 | AstraZeneca Pharmaceuticals LP ($49.69) |
| 2018 | $769.51 | 6 | Actelion Clinical Research, Inc. ($295.00) |
| 2017 | $1,601 | 6 | Actelion Pharmaceuticals, Ltd ($1,601) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.65 | General |
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 01/30/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 01/09/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Respiratory | ||||||
| 12/05/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Immunology | ||||||
| 10/03/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Respiratory | ||||||
| 09/05/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Immunology | ||||||
| 07/18/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory | ||||||
| 07/11/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/21/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Immunology | ||||||
| 02/07/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2018 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 10/05/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $11.54 | General |
| Category: Allergy/Immunology | ||||||
| 09/20/2018 | Actelion Pharmaceuticals, Ltd | — | Travel and Lodging | Cash or cash equivalent | $285.34 | General |
| 03/29/2018 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/27/2018 | Actelion Clinical Research, Inc. | OPSUMIT MACITENTAN (Drug) | — | Cash or cash equivalent | $295.00 | Research |
| Study: TOMORROW - AC-055-312 • Category: CARDIOVASCULAR DISORDERS | ||||||
| 02/21/2018 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug) | Food and Beverage | In-kind items and services | $145.87 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 01/12/2017 | Actelion Pharmaceuticals, Ltd | OPSUMIT MACITENTAN (Drug) | Travel and Lodging | Cash or cash equivalent | $1,162.45 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 01/12/2017 | Actelion Pharmaceuticals, Ltd | OPSUMIT MACITENTAN (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 01/12/2017 | Actelion Pharmaceuticals, Ltd | OPSUMIT MACITENTAN (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 01/12/2017 | Actelion Pharmaceuticals, Ltd | OPSUMIT MACITENTAN (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOMORROW - AC-055-312 | Actelion Clinical Research, Inc. | $295.00 | 1 |
About Dr. Amy Dimarino, DO
Dr. Amy Dimarino, DO is a Pediatrics healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710171756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Dimarino, DO has received a total of $2,647 in payments from pharmaceutical and medical device companies, with $19.03 received in 2021. These payments were reported across 27 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($1,767).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Pulmonology
- Location Cleveland, OH
- Active Since 09/04/2007
- Last Updated 05/07/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1710171756
Products in Payments
- OPSUMIT MACITENTAN (Drug) $2,042
- NUCALA (Biological) $88.56
- FASENRA (Drug) $69.47
- Xolair (Biological) $65.68
- ZENPEP (Drug) $26.82
- CREON (Drug) $19.03
- ImmunoCAP (Device) $11.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Cleveland
Kristie Ross, Md, MD
Pediatrics — Payments: $23,787
Pediatrics $23,787
David Kaelber, Md, MD
Pediatrics — Payments: $18,740
Pediatrics $18,740
Dr. Sarah Macleish, D.o, D.O
Pediatrics — Payments: $15,446
Pediatrics $15,446
Ryan Summers
Pediatrics — Payments: $10,150
Pediatrics $10,150
Dr. John Lozier, Md, MD
Pediatrics — Payments: $9,511
Pediatrics $9,511
Roy Kim, M.d, M.D
Pediatrics — Payments: $7,353
Pediatrics $7,353